RADAR: A randomised phase III trial with a PET response adapted design comparing ABVD +/- ISRT with A2VD +/- ISRT in patients with previously untreated stage IA/IIA Hodgkin lymphoma
- Kim Linton (Contributor)
Activity: Internal positions, career professional development, other peer review and other › Other › Research